Laddar...
Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L
The emergence of SARS-CoV-2 in late 2019, and the subsequent COVID-19 pandemic, has led to substantial mortality, together with mass global disruption. There is an urgent need for novel antiviral drugs for therapeutic or prophylactic application. Cathepsin L is a key host cysteine protease utilized...
Sparad:
| I publikationen: | bioRxiv |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Cold Spring Harbor Laboratory
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7781308/ https://ncbi.nlm.nih.gov/pubmed/33398273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.12.23.424111 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|